4//SEC Filing
Quinn William P. 4
Accession 0000950170-25-063840
CIK 0001641281other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 8:35 PM ET
Size
8.6 KB
Accession
0000950170-25-063840
Insider Transaction Report
Form 4
Quinn William P.
DirectorPresident, CEO and CFO
Transactions
- Purchase
Common Stock
2024-06-06$0.64/sh+2,500$1,594→ 38,772 total - Purchase
Common Stock
2024-12-16$0.50/sh+2,500$1,241→ 41,272 total - Award
Stock Option (Right to Buy)
2025-05-01+700,000→ 700,000 totalExercise: $0.35Exp: 2035-04-30→ Common Stock (700,000 underlying)
Footnotes (3)
- [F1]and therefore exempt under Rule 16b-3(c)
- [F2]Shares acquired under the issuer's Employee Stock Purchase Plan.
- [F3]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025.
Documents
Issuer
Bolt Biotherapeutics, Inc.
CIK 0001641281
Entity typeother
Related Parties
1- filerCIK 0001724190
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 8:35 PM ET
- Size
- 8.6 KB